Call Us for More Information
800.615.2270

Clinical Trials - Not Recruiting

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: September 27, 2011

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: March 1, 2012

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: June 21, 2011

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: February 26, 2011

Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: January 12, 2012

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma, Metastatic Cancer
  • Status: Active, not recruiting
  • Last Updated: March 30, 2012

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: February 26, 2011

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: July 23, 2008

Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)

  • Conditions: Malignant Pleural Mesothelioma, Solid Tumors
  • Status: Active, not recruiting
  • Last Updated: October 31, 2011

Response Evaluation in Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: September 1, 2010

Tomotherapy Treatment for Mesothelioma

  • Conditions: Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: April 5, 2012

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Withdrawn
  • Last Updated: March 21, 2012

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: April 14, 2009

Sorafenib in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: March 22, 2011

Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: February 6, 2009

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: July 23, 2008

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Not yet recruiting
  • Last Updated: September 3, 2011

Dasatinib in Resectable Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: January 26, 2012

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: June 11, 2010

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Terminated
  • Last Updated: August 31, 2009

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: December 17, 2011

Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: February 12, 2011

S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: July 18, 2011

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

  • Conditions: Breast Cancer, Endometrial Cancer, Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: July 23, 2008

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma, Perioperative/Postoperative Complications
  • Status: Active, not recruiting
  • Last Updated: August 19, 2009

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: April 21, 2009

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

  • Conditions: Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: January 20, 2012

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant, Pleural, Mesothelioma
  • Status: Not yet recruiting
  • Last Updated: March 30, 2012

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Terminated
  • Last Updated: October 23, 2009

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

  • Conditions: Pleural Mesothelioma, Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: October 30, 2009

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

  • Conditions: Pleural Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: January 25, 2012

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: December 30, 2011

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: April 3, 2009

Sorafenib in Previously Treated Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: August 3, 2009

An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: December 7, 2011

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

  • Conditions: Non-Small Cell Lung Cancer and Pleural Mesothelioma
  • Status: Terminated
  • Last Updated: March 15, 2012

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

  • Conditions: Malignant Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: February 6, 2009

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

  • Conditions: Cancer
  • Status: Active, not recruiting
  • Last Updated: August 7, 2010

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

  • Conditions: Pleural Mesothelioma, Malignant Pleural Mesothelioma
  • Status: Active, not recruiting
  • Last Updated: December 15, 2009

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

  • Conditions: Malignant Epithelial Mesothelioma, Adenocarcinoma of the Pancreas, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma of the Ovaries
  • Status: Terminated
  • Last Updated: February 19, 2009

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

  • Conditions: Breast Cancer, Colorectal Cancer, Lung Cancer, Malignant Mesothelioma, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Thymoma and Thymic Carcinoma
  • Status: Active, not recruiting
  • Last Updated: January 12, 2012

CryoSpray Ablation(tm)Thoracic Patient Registry

  • Conditions: Lung Cancer, Emphysema, Chronic Bronchitis, COPD, Asthma, Sarcoidosis, Mesothelioma
  • Status: Withdrawn
  • Last Updated: May 27, 2009

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

  • Conditions: Lung Cancer, Mesothelioma, Malignant Airway Obstruction
  • Status: Terminated
  • Last Updated: August 17, 2010

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

  • Conditions: Lung Cancer, Malignant Mesothelioma, Metastatic Cancer, Nonmalignant Neoplasm, Precancerous Condition
  • Status: Withdrawn
  • Last Updated: March 21, 2012

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

  • Conditions: Lung Cancer, Malignant Mesothelioma, Metastatic Cancer, Thymoma and Thymic Carcinoma
  • Status: Active, not recruiting
  • Last Updated: July 21, 2010

Gene Therapy for Pleural Malignancies

  • Conditions: Pleural Mesothelioma, Metastatic Pleural Effusions
  • Status: Active, not recruiting
  • Last Updated: September 29, 2010

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  • Conditions: Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma, Ovarian Stromal Cancer, Pseudomyxoma Peritonei, Recurrent Colon Cancer, Recurrent Malignant Mesothelioma, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Stage III Colon Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Colon Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Unspecified Childhood Solid Tumor, Protocol Specific
  • Status: Active, not recruiting
  • Last Updated: November 30, 2011

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

  • Conditions: Advanced Malignant Mesothelioma, Extensive Stage Small Cell Lung Cancer, Lung Metastases, Recurrent Malignant Mesothelioma, Recurrent Non-small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
  • Status: Withdrawn
  • Last Updated: March 16, 2012

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

  • Conditions: Solid Tumor, Lymphoma
  • Status: Active, not recruiting
  • Last Updated: April 28, 2011

Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)

  • Conditions: Metastatic Non-squamous Non Small Cell Lung Cancer
  • Status: Active, not recruiting
  • Last Updated: October 31, 2011

Rapamycin With Grapefruit Juice for Advanced Malignancies

  • Conditions: Tumors, Neoplasm Metastasis
  • Status: Active, not recruiting
  • Last Updated: February 12, 2009

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

  • Conditions: Ovarian Neoplasms, Colorectal Neoplasms, Melanoma, Small Cell Lung Cancer, Liposarcoma
  • Status: Active, not recruiting
  • Last Updated: January 6, 2012

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

  • Conditions: Cancer, Neoplasms, Tumors
  • Status: Not yet recruiting
  • Last Updated: March 28, 2012

Ixabepilone and Pemetrexed/Solid Tumors

  • Conditions: Advanced Solid Tumors
  • Status: Withdrawn
  • Last Updated: July 23, 2010

Study of Pemetrexed for Second-Line Pancreas Cancer

  • Conditions: Pancreas Cancer
  • Status: Terminated
  • Last Updated: March 23, 2011

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

  • Conditions: Cancer of the Head and Neck
  • Status: Active, not recruiting
  • Last Updated: May 6, 2010
mesothelioma-packet
Name:
Address:
City, State, Zip:
Country:
Phone Number:
Email:
Diagnosis:
Comments:
terms of use